LEFLUNOMIDE APOTEX leflunomide 10mg tablets blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

leflunomide, Quantity: 10 mg

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

Leflunomide

Għamla farmaċewtika:

Tablet, uncoated

Kompożizzjoni:

Excipient Ingredients: lactose; crospovidone; colloidal anhydrous silica; magnesium stearate

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

30 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

LEFLUNOMIDE APOTEX is indicated for the treatment of: active rheumatoid arthritis; active psoriatic arthritis. GenRx Leflunomide is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. The combined use of GenRx Leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Sommarju tal-prodott:

Visual Identification: White, round, tablet. Engraved "LE" over "10" on one side and "APO" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2008-07-14